As a consequence of an increased flux through the sorbitol pathway fructose levels rise in various tissues in diabetes. Also, in vitro nonenzymatic fructosylation of protein induces the generation of fluorescence at a rate 10 times greater than glucosylation. The administration of sorbinil, an aldose reductase inhibitor known to lower tissue fructose concentration, to experimental diabetic rats led to a decrease in the fluorescence related to advanced Maillard products in their skin collagen. This effect is consistent with the in vivo occurrence of nonenzymatic fructosylation of collagen. A potential pathogenetic role for this posttranslational modification in diabetic complications should be considered.
Introduction
Despite significant improvements in the control of blood glucose levels by diet or drug therapy the long-term complications of diabetes are still leading causes of death and morbidity (1, 2) . Among the various biochemical processes that have been proposed as underlying the pathogenesis of these complications, nonenzymatic glucosylation' of proteins has been the focus of increasing attention during the last decade (3) (4) (5) . The term nonenzymatic glycosylation collectively denotes a multireaction pathway, also termed the Maillard reaction, whereby reducing sugars react with protein amino groups and form Schiff base-mediated adducts that rearrange into more stable glycoconjugates. If the sugar is glucose the rearrangement is known as the Amadori rearrangement and the glycoconjugate is a ketoamine-linked I-deoxy hexose. The products of the rearrangement undergo further transformations which lead to the emergence of poorly characterized fluorescent structures. Recent evidence (6) supports the view that these 1. Throughout the text the word "glycosylation" has been employed to denote the nonenzymatic protein modification by any sugar whereas "glucosylation" denotes exclusively the reaction of glucose with protein. fluorescent moieties mediate the establishment of crosslinks between protein molecules which may underlie some pathogenetic events in the complications of diabetes (7) .
Alternative hypotheses to explain the complications of diabetes are based on the operation of the sorbitol pathway. This is a metabolic shunt, the net result of which is the conversion ofglucose to fructose (Scheme I) with the formation of sorbitol as an intermediate metabolite. Reduction ofglucose is catalyzed by the NADPH-requiring enzyme aldose reductase (alditol: NADP oxidoreductase, E.C. 1.1.1.21). The resulting sorbitol can be oxidized enzymatically to fructose through the action of sorbitol dehydrogenase (L-iditol:NAD oxidoreductase, E.C. 1.1.1.14), with NAD+ serving as a coenzyme. An explanation of the long-term complications ofdiabetes such as cataracts and peripheral neuropathy (8, 9 ) is based on the accumulation of sorbitol within cells. Sorbitol accumulation occurs because the cell membrane is impermeable to sorbitol, and thus, a higher flux through the sorbitol pathway, as in diabetes, would result in a rise in the intracellular level of the polyol. This, in turn, would induce an increase in the osmotic pressure leading to the transfer of water to the intracellular compartment, ionic leakage, and cell damage.
In contrast to the role of sorbitol the second step in the sorbitol pathway, the generation of fructose, has received, to our knowledge, almost no attention although fructose levels have been shown to increase up to 23-fold in tissues ofdiabetic animals where the sorbitol pathway is active (10) . Numerous other studies have documented elevated intracellular concentrations of fructose in diabetic animals (1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . The concept that the sorbitol pathway might mediate diabetic complications by mechanisms other than those related to the "osmotic hypothesis" described above was suggested to us as a result of considerations of the following experimental findings: incubation of BSA with 0.5 M fructose led to the generation of protein-bound fluorescent products at a rate 10 times greater than when glucose was used as the glycosylating sugar under the same conditions (14) . We, therefore, concluded that fructose was a much more efficient glycosylating sugar than glucose. 
Methods
Two groups of male Sprague-Dawley rats weighing an average of 160 g were rendered diabetic by a single subcutaneous injection of streptozotocin (80 mg/kg body weight). One of these groups of diabetic rats was fed a diet supplemented with sorbinil (400 mg/kg ofrodent laboratory chow), which was kindly provided by Pfizer, Inc., Groton, CT.
After 56 d of treatment the rats were killed by cervical dislocation immediately after withdrawal of blood from the retrobulbar blood vessels.
Solubilization ofskin collagen by bacterial collagenase. Fig. 1 were scanned in the Perkin-Elmer spectrofluorometer. Full pen deflection corresponded to 1 V. Excitation wavelength was 350 nm. All samples were taken to a concentration of hydroxyproline of 400 jg/ml.
Nonenzymatically glycosylated BSA solutions, obtained after incubation with sugars as described above, were taken to a protein concentration of 0.365 mg/ml (as determined by the Lowry method) and the emission spectra taken as described.
Results
Relevant blood glucose values and body weight changes of the rats are summarized in Table I . Control rats gained a mean of 150.8 g during the period of observation while diabetic rats lost a mean of 16.18 g (untreated) and 22.19 g (sorbinil-treated). Fig. 1 shows the results on the fluorescence associated with the material that was solubilized from the skin by purified bacterial collagenase. Preliminary surveys on samples from 50 rats revealed that the solubilized material had an amino acid composition almost identical to that of type I collagen obtained from rat skin according to the method ofChandrakasan et al. (18) . A minor proportion of cysteine indicated that a small percentage of type III collagen (19) , also present in the skin, was likewise solubilized. In the same preliminary study no significant differences were found in the yield of collagenase-released hydroxyproline-containing material between diabetic and control animals. Control rat skin yielded 94.2±22.44 SD nmol of hydroxyproline/mg wet tissue, while diabetic rat skin yielded 90.97±21.46 SD nmol (control vs. diabetic P < 0.6). The normalized fluorescence associated with skin collagen of the untreated diabetic rats (1 17±7) was almost twice that of control rats (63±5). After treatment with sorbinil fluorescence was significantly (P < 0.003) reduced (87±4). related to the later stages of the Maillard reaction. The dose of sorbinil used in this study has previously been shown to decrease fructose levels in tissues where the sorbitol pathway is active (12, 15, 16) . Since the inhibitor did not affect the blood glucose levels of the diabetic rats (Table I) , as previously reported (12, 15, 16) , the decreased collagen fluorescence cannot be explained by a reduction in the extent of nonenzymatic glucosylation. The results are, however, consistent with a decreased generation of fluorophors that arise from nonenzymatic fructosylation of proteins. It should be noted, however, that administration of aldose reductase inhibitors has been shown to decrease sorbitol values more efficiently than fructose levels (12, 15, 16) . This may explain, in part, the inability of sorbinil to reverse collagen-associated fluorescence completely. Another explanation for the incomplete reversal of the high collagen fluorescence after sorbinil treatment is the probable coexistence of nonenzymatic glucosylation and fructosylation, which would be expected to occur under conditions of hyperglycemia uncorrected by sorbinil treatment. As already mentioned, nonenzymatic glucosylation also leads to the generation of protein-bound fluorescent moieties.
The extent of nonenzymatic glycosylation, which is a very slow reaction, for a given protein is largely dependent on its half-life. Thus, it could be hypothesized that the decreased fluorescence induced by sorbinil is a reflection of increased collagen turnover. This is highly improbable, based on the almost identical growth curves of the two groups of diabetic rats and on the documented lack of effect of sorbinil on collagen synthesis (20) .
These considerations have led us to the view that our results provide presumptivc evidence for the occurrence of nonenzymatic fructosylation in vivo. It has been proposed that aldose reductase inhibitors might have beneficial effects through a mechanism that involves a replenishment of reduced glutathione, which would lead to decreased disulfide bridge-mediated protein crosslinks upon nonenzymatic glycosylation (21) . Fluorophors resulting from nonenzymatic glucosylation, however, appear to be generated at a higher rate under nonoxidative conditions (22) , so our results cannot be satisfactorily explained by this hypothesis if fructosylation proceeds by analogous mechanisms.
The sorbitol pathway is generally thought to be an intracellular pathway, while the present study deals with the structural modification of collagen, which is an extracellular protein in its mature form. However, a recent report proposed extracellular sorbitol accumulation as a pathogenetic determinant in the syndrome of limited joint mobility (23), one ofthe sequelae of long-standing juvenile diabetes (24) . Increased extracellular polyol concentration would lead to a higher degree of collagen hydration, which might underlie the pathophysiology of virtually all the complications of diabetes in collagencontaining organs. The general validity of the "collagen hydration" hypothesis (25, 26) must be questioned since nerve water content of peripheral nerve has been found unaltered in experimental diabetic rats (27) . Also, the nonenzymatic fructosylation concept has the potential to provide an explanation of the pathology associated not only with collagenous proteins but also with noncollagenous proteins, such as lens crystallins and red cell membrane proteins, as well. Although fructose is generated intracellularly, there is evidence that significant diffusion of the sugar into the culture medium occurs in organ culture of aortas (28) . Also, a recent report (29) indicated that sorbinil was effective at decreasing the concentration of sorbitol in human endothelial cells cultured in the presence of high glucose concentrations. This finding demonstrates that the sorbitol pathway is present in all kinds of vascular tissue and that the levels of sorbitol, and presumably of fructose, can be modulated by sorbinil. Leakage of fructose from vascular tissue, where the sorbitol pathway is active, to the extracellular collagenous matrix of the skin would be favored by the high degree of vascularization of this tissue (30) .
In summary, our results are compatible with the in vivo occurrence of protein nonenzymatic fructosylation and warrant further exploration aimed at providing direct evidence of this posttranslational modification, such as identification of the corresponding advanced Maillard reaction products. If nonenzymatic fructosylation represents a major event, then the value of protein-bound fluorescence as a clinical marker (31) and its pathophysiological significance should be reassessed.
